Kiora Pharmaceuticals (KPRX) EPS (2015 - 2026)
Kiora Pharmaceuticals (KPRX) EPS from Mar 31, 2015 to Mar 31, 2026. The TTM Kiora Pharmaceuticals (KPRX) EPS is -$2.96. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Kiora Pharmaceuticals (KPRX) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -26.45% |
| 3 Years TTM | -48.22% |
| 5 Years TTM | -38.04% |
| 10 Years TTM | -38.49% |
| All Time TTM | -38.49% |
Annual EPS change of Kiora Pharmaceuticals (KPRX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.61 | -78.97% |
| 2025 | -$2.88 | -340.87% |
| 2024 | $1.20 | -108.19% |
| 2023 | -$14.61 | -78.53% |
| 2022 | -$68.04 | +1079.23% |
| 2021 | -$5.77 | -83.50% |
| 2020 | -$34.96 | -30.98% |
| 2019 | -$50.66 | -57.47% |
| 2018 | -$119.11 | -56.81% |
| 2017 | -$275.81 | -41.82% |
| 2016 | -$474.08 | +20.18% |
| 2015 | -$394.49 | N/A |
Comparison Kiora Pharmaceuticals (KPRX) five years EPS CAGR with competitors
Kiora Pharmaceuticals (KPRX) five years EPS CAGR is -43.34%.